Product Information
BIDIL 20 MG-37.5 MG TABLET is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $4.3452 per EA under NDC 24338001009. Its NADAC has been published 264 times since Nov 11, 2020.
Strength
37.5; 20 mg/1; mg/1
Manufacturer
Azurity Pharmaceuticals Inc.NDC
24338001009
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATEApproval Type
New Drug (NDA)
FDA Application
NDA020727On Market Since
12/5/2012
Pharmacological Classes
Price Statistics
The NADAC for BIDIL 20 MG-37.5 MG TABLET has been published 264 times since Nov 11, 2020, and over the history we have for it it has risen 21.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3452 per EA |
|---|---|
| All-time high | $4.4016 (Sep 11, 2024) |
| All-time low | $3.5578 (Dec 23, 2020) |
| 52-week high | $4.3817 |
| 52-week low | $4.3452 |
| Median price | $4.1927 |
| Average price | $4.0889 |
| Largest weekly change | +10.0% (Oct 12, 2022) |
| Weeks tracked | 264 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Hydralazine hydrochloride and Isosorbide dinitrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BIDIL 20 MG-37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BIDIL 20 MG-37.5 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $4.3452 per EA (NDC 24338001009), effective Jun 24, 2026.
How has the price of BIDIL 20 MG-37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BIDIL 20 MG-37.5 MG TABLET has risen 21.3%. It has been tracked across 264 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for BIDIL 20 MG-37.5 MG TABLET?
Since Nov 11, 2020, the NADAC for BIDIL 20 MG-37.5 MG TABLET has ranged from a low of $3.5578 (Dec 23, 2020) to a high of $4.4016 (Sep 11, 2024), with a median of $4.1927 per EA.
Are there cheaper alternatives to BIDIL 20 MG-37.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BIDIL 20 MG-37.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures BIDIL 20 MG-37.5 MG TABLET?
BIDIL 20 MG-37.5 MG TABLET (NDC 24338001009) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification